Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up

Daniel J Wallace, Caroline Gordon, Vibeke Strand, Kathryn Hobbs, Michelle Petri, Kenneth Kalunian, Frederic Houssiau, Paul P Tak, David A Isenberg, Lexy Kelley, Brian Kilgallen, Anna N Barry, William A Wegener, David M Goldenberg

Research output: Contribution to journal › Article › peer-review

88 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up'. Together they form a unique fingerprint.

Medicine & Life Sciences